• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

High User Acceptance of a Retina e-Learning App in Times of Increasing Digitalization of Medical Training for Ophthalmologists
Conclusions: The COVID-19 pandemic has led to a significant change in training behaviour in ophthalmology towards e-learning and online courses, which has not been accompanied by a general decline in training activity. The exemplarily investigated application showed a high user acceptance among ophthalmologists.Ophthalmologica
Source: Ophthalmologica - May 2, 2022 Category: Opthalmology Source Type: research

IJERPH, Vol. 18, Pages 5846: Assessment of Patients ’ Confidence Regarding a New Triage Concept in a Medical Retina Clinic during the First COVID-19 Outbreak
Conclusions: Our triage seemed to be useful in optimizing access to treatment for patients with retinal diseases. An excellent rating of patients’ confidence in the triage and satisfaction regarding the received treatment during the first COVID-19 outbreak could be achieved.
Source: International Journal of Environmental Research and Public Health - May 29, 2021 Category: Environmental Health Authors: Anahita Bajka Maximilian Robert Justus Wiest Timothy Hamann Mario Damiano Toro Sandrine Anne Zweifel Tags: Article Source Type: research

Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Purpose: The temporary cessation and profound changes in ophthalmic care delivery that occurred as a result of the coronavirus disease 2019 (COVID-19) pandemic have yet to be fully understood. Our objective is to assess patients’ self-reported impact of health care lockdown measures on their fears and anxieties during the crisis period of the COVID-19 pandemic in New York City. Methods: We conducted a digital, self-reported, patient care survey distributed by an e-mail at Columbia University’s Department of Ophthalmology outpatient faculty practice. Inclusion criteria were age greater than or equal to 18 yea...
Source: Journal of Glaucoma - August 1, 2021 Category: Opthalmology Tags: Quality of Life and Medical Treatment: Original Studies Source Type: research

Ad hoc announcement pursuant to Art. 53 LR Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news

New Developments in FDA Regulation of AI
CONCLUSION On the whole, FDA seems very enthusiastic about the possibilities for AI to improve healthcare.  That’s gratifying to see. While progress in the development of a new regulatory approach is slow, that’s also not all bad. It would be worse in many ways for FDA to act precipitously.  These are complicated issues, and it will take time to develop an appropriate approach, in part because it will take time for FDA to acquire enough expertise. And most likely, whatever new approach we come up with will require new statutory authority. That said, it is incumben...
Source: MDDI - April 10, 2020 Category: Medical Devices Authors: Bradley Merrill Thompson Tags: Regulatory and Compliance Source Type: news

COVID-19 Vaccine-Associated Ocular Adverse Effects: An Overview
CONCLUSIONS: Evidence regarding the ocular adverse effects does not outweigh the benefits of SARS-CoV-2 vaccination in patients with pre-existing systemic or ophthalmic diseases. This review provides insights into the possible temporal association between reported ocular adverse events and SARS-CoV-2 vaccines; however, further investigations are required to identify the link between potential causality and pathological mechanisms.PMID:36366386 | DOI:10.3390/vaccines10111879
Source: Herpes - November 11, 2022 Category: Infectious Diseases Authors: Parul Ichhpujani Uday Pratap Singh Parmar Siddharth Duggal Suresh Kumar Source Type: research

Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
ConclusionA possible future clinical perspective for patients with COVID-19 treated with HCQ/CQ could reside in the multidisciplinary collaboration between ophthalmologists monitoring the risk of HCQ/CQ-related retinal toxicity and those physicians treating COVID-19 infection.
Source: International Ophthalmology - September 17, 2020 Category: Opthalmology Source Type: research

What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects
Eur J Ophthalmol. 2020 Oct 8:1120672120958323. doi: 10.1177/1120672120958323. Online ahead of print.ABSTRACTWithin the COVID-19 pandemic context, the WHO has proposed a list of medicines to treat patients with severe acute respiratory syndrome (SARS-CoV-2). An analysis of their ocular side effects was performed. Only chloroquine and hydroxychloroquine were found to have an ocular impact in the medium and long-term. Detailed search strategies were performed in EMBASE, MEDLINE, SCOPUS and WOS Core Collection. Additionally, the worldwide ongoing clinical trials including chloroquine or hydroxychloroquine were evaluated, and t...
Source: European Journal of Ophthalmology - April 8, 2021 Category: Opthalmology Authors: Isabel Fambuena-Muedra Marta Jim énez-García Sarah Hershko Irene Altemir-G ómez Ana Tobarra-L ópez Source Type: research

Diagnostic concordance of telemedicine as compared to face-to-face care in primary health care clinics in rural India: a randomized crossover trial
CONCLUSIONS: Provider-to-provider telemedicine, where nurses at Health and Wellness Centres connect with remote physicians to provide care for patients they would otherwise have referred to a tertiary facility, is a feasible and safe intervention. Telemedicine is less reliable than in-person care but a safe and effective alternative where in-person care cannot be provided. We found it most effective for managing high-burden primary health conditions such as hypertension, diabetes, and remote antenatal care. The use of a digital assistant to facilitate the collection of an evidence-based medical history can result in more e...
Source: Rural Remote Health - May 2, 2023 Category: Rural Health Authors: Neha Verma Bimal Buch Radha Taralekar Soumyadipta Acharya Source Type: research

Pages: 1  2  3  4  5  6  7